According to IMARC Group's latest research report, titled "Sterility Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028," presents a comprehensive analysis of the industry, covering sterility testing market size, opportunity, statistics size, share, trends, demand, and growth prospects. The report also provides competitor and regional analysis and showcases the contemporary advancements in the global market.

How big is the Sterility Testing Market?

The global sterility testing market size reached US$ 936 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,732.8 Million by 2028, exhibiting a growth rate (CAGR) of 10.30% during 2023-2028.

What is Sterility Testing?

Sterility testing refers to the procedure of determining the presence or absence of microorganisms and harmful pathogens in a sample or on a product. It includes direct inoculation, immersion method, membrane filtration, and molecular techniques, such as polymerase chain reaction (PCR). Sterility testing is widely used for the manufacturing process, regulatory compliance, product stability, quality control, device safety, scientific research, and environmental monitoring. It provides more accurate, faster, and reliable testing results, which allow early detection, prevent outbreaks, enhance patient safety, and minimize the risk of infections and other diseases. In addition to this, sterility testing also aids companies in increasing productivity, preventing product recalls, improving process efficiency, and identifying sources of contamination. As a result, this process finds widespread applications across the biotechnology, pharmaceutical, and healthcare industries.

Get Free Sample Copy of Report at – https://www.imarcgroup.com/sterility-testing-market/requestsample

What are the Growth Prospects and Trends in the Sterility Testing Market?

The escalating demand for this procedure in the pharmaceutical and biopharmaceutical manufacturing processes to ensure the safety and efficacy of capsules, tablets, vaccines, injectables, drugs, insulin, eye drops, ointments, aerosols, creams, gels, powders, and nebulizers is primarily driving the sterility testing market. Besides this, the elevating requirement for this technique in producing various medical devices, such as forceps, surgical scissors, catheters, contact lenses, scalpels, infusion pumps, pacemakers, artificial joints, bone grafts, etc., is further augmenting the market growth. Moreover, the development of quick microbial detection systems that use polymerase chain reaction (PCR) and next-generation sequencing (NGS) to detect contamination quickly and accurately is also catalyzing the global market. Apart from this, the introduction of robotics and automation technology to handle large volumes of samples, reduce human errors, and improve the efficiency of the testing process is acting as another significant growth-inducing factor. Furthermore, the rising concerns among the masses toward healthcare-associated infections (HAI) and the inflating need for this procedure in the biotechnology industry are anticipated to propel the sterility testing market over the forecasted period.

Who are the key Players Operating in the Industry?

  • BioMérieux SA
  • Charles River Laboratories International Inc.
  • Merck KGaA
  • Rapid Micro Biosystems Inc.
  • Sartorius AG
  • SGS S.A.
  • Sotera Health Company
  • Steris Corporation
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec

What is included in Market Segmentation?

The report has segmented the market into the following categories:

Product and Service Insights:

  • Instruments
  • Kits and Reagents
  • Services

Test Type Insights:

  • Membrane Filtration
  • Direct Inoculation
  • Others

Application Insights:

  • Pharmaceutical and Biological Manufacturing
  • Medical Device Manufacturing
  • Others

End User Insights:

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Others

Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key Highlights of the Report:

  • Market Performance 
  • Market Outlook
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Who we are:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800